Cite
Impact of Double/Triple Hit Lymphoma on Radiation Therapy Efficacy Among Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
MLA
Kim, A., et al. “Impact of Double/Triple Hit Lymphoma on Radiation Therapy Efficacy Among Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.” International Journal of Radiation Oncology, Biology, Physics, vol. 102, Nov. 2018, pp. S123–24. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2018.06.309.
APA
Kim, A., Stevenson, P., Cassaday, R., Soma, L., Fromm, J., Gopal, A. K., Smith, S. C., Till, B. G., Lynch, R., Russell, K. J., & Tseng, Y. D. (2018). Impact of Double/Triple Hit Lymphoma on Radiation Therapy Efficacy Among Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma. International Journal of Radiation Oncology, Biology, Physics, 102, S123–S124. https://doi.org/10.1016/j.ijrobp.2018.06.309
Chicago
Kim, A., P. Stevenson, R. Cassaday, L. Soma, J. Fromm, A.K. Gopal, S.C. Smith, et al. 2018. “Impact of Double/Triple Hit Lymphoma on Radiation Therapy Efficacy Among Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.” International Journal of Radiation Oncology, Biology, Physics 102 (November): S123–24. doi:10.1016/j.ijrobp.2018.06.309.